Takayasu’s arteritis progression on anti-TNF biologics: a case series
- 337 Downloads
Takayasu’s arteritis (TA) is a rare granulomatous vasculitic disease that affects the aorta and its major branches. Recent studies have suggested that anti-TNFα biological therapies are highly effective in treating TA refractory to conventional immunosuppressive therapy. We describe two patients with TA: one with progressive TA despite management with two different anti-TNFα agents, infliximab and adalimumab, and another who developed TA while treated with infliximab for the management of pre-existing Crohn’s disease. From our observations, we believe that a multicentered randomized study should be designed to assess the extent of resistance to these agents when different therapeutic doses are employed for managing TA.
KeywordsAnti-TNF biologics Crohn’s disease Infliximab Takayasu’s arteritis
- 2.Reny JL et al (2003) Association of Takayasu’s arteritis and Crohn’s disease: results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris) 154(2):85–90Google Scholar